Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease

Updates Surg. 2021 Oct;73(5):2029-2030. doi: 10.1007/s13304-021-01008-4. Epub 2021 Mar 3.

Authors

Gaetano Gallo¹, Maurizio Ronconi², Mario Trompetto³

Affiliations

¹ Department of Medical and Surgical Sciences, University of Catanzaro, Catanzaro, Italy. gallog@unicz.it.
² Department of General Surgery, ASST-Spedali Civili-Gardone V.T Hospital, Brescia, Italy.
³ Department of Colorectal Surgery, S. Rita Clinic, Vercelli, Italy.

No abstract available

Publication types

Letter

MeSH terms

Hemorrhoids* / therapy
Humans
Outpatients
Polidocanol / therapeutic use
Sclerosing Solutions
Sclerotherapy*
Treatment Outcome

Substances

Sclerosing Solutions
Polidocanol